SurModics Newsroom

Barrington Maintains SurModics(SRDX.US) With Hold Rating

Futu NewsNov 7 22:35

Surmodics Analyst Ratings

BenzingaNov 7 17:44

Needham Maintains SurModics(SRDX.US) With Hold Rating

Futu NewsNov 7 00:32

Barrington Maintains SurModics(SRDX.US) With Hold Rating

Futu NewsAug 14 21:33

Surmodics Analyst Ratings

BenzingaAug 6 01:52

Needham Maintains SurModics(SRDX.US) With Hold Rating

Futu NewsAug 5 23:31

Barrington Maintains SurModics(SRDX.US) With Hold Rating

Futu NewsAug 1 21:35

SurModics Holds Steady Amid Acquisition Uncertainty: A Market Perform Rating

TipRanksAug 1 21:23

Lake Street Maintains SurModics(SRDX.US) With Hold Rating, Maintains Target Price $43

Futu NewsJul 31 21:33

SurModics (SRDX) Receives a Hold From Lake Street

TipRanksJul 31 20:57

SurModics (SRDX) Was Downgraded to a Hold Rating at Barrington

TipRanksMay 30 21:18

Sidoti & Co. Downgrades Surmodics to Neutral, Announces $43 Price Target

BenzingaMay 30 00:45

Sidoti & Co. : The Surmodics (SRDX.US) rating was downgraded from buying to neutral, and the target price was $43.00.

Zhitong FinanceMay 30 00:41

Surmodics Analyst Ratings

BenzingaMay 29 22:30

SurModics (SRDX) Was Downgraded to a Hold Rating at Needham

TipRanksMay 29 22:19

SurModics (SRDX) Gets a Buy From Lake Street

TipRanksMay 29 21:08

Analysts Are Bullish on These Healthcare Stocks: Assertio Therapeutics (ASRT), SurModics (SRDX)

TipRanksMay 29 21:00

Barrington Research: Maintaining the Surmodics (SRDX.US) rating, adjusted from better than market to better than market rating, and adjusted the target price from $71.00 to $71.00.

Zhitong FinanceMay 3 02:31

Surmodics Analyst Ratings

BenzingaMay 3 02:30

Barrington Ups Price Target on SurModics to $71 From $70, Maintains Outperform Rating

MT NewswiresMay 2 21:39